nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—ACE—forelimb zeugopod—skin cancer	0.0781	0.222	CbGeAlD
Rescinnamine—ACE—forelimb—skin cancer	0.0392	0.111	CbGeAlD
Rescinnamine—ACE—hindlimb—skin cancer	0.0353	0.1	CbGeAlD
Rescinnamine—ACE—arm—skin cancer	0.0337	0.0958	CbGeAlD
Rescinnamine—ACE—appendage—skin cancer	0.0303	0.0861	CbGeAlD
Rescinnamine—Sunburn—Vemurafenib—skin cancer	0.0284	0.0438	CcSEcCtD
Rescinnamine—Skin infection—Imiquimod—skin cancer	0.0242	0.0374	CcSEcCtD
Rescinnamine—ACE—nerve—skin cancer	0.0215	0.061	CbGeAlD
Rescinnamine—ACE—endothelium—skin cancer	0.0183	0.0519	CbGeAlD
Rescinnamine—Tearing eyes—Docetaxel—skin cancer	0.0178	0.0274	CcSEcCtD
Rescinnamine—ACE—blood vessel—skin cancer	0.0169	0.0479	CbGeAlD
Rescinnamine—Eyelid oedema—Imiquimod—skin cancer	0.0145	0.0224	CcSEcCtD
Rescinnamine—Pigmentation disorder—Temozolomide—skin cancer	0.0131	0.0203	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Imiquimod—skin cancer	0.0123	0.019	CcSEcCtD
Rescinnamine—ACE—neck—skin cancer	0.0121	0.0343	CbGeAlD
Rescinnamine—Psoriasis—Imiquimod—skin cancer	0.0116	0.018	CcSEcCtD
Rescinnamine—Tooth disorder—Imiquimod—skin cancer	0.0113	0.0174	CcSEcCtD
Rescinnamine—Herpes zoster—Imiquimod—skin cancer	0.00971	0.015	CcSEcCtD
Rescinnamine—Skin irritation—Fluorouracil—skin cancer	0.00934	0.0144	CcSEcCtD
Rescinnamine—Tingling sensation—Imiquimod—skin cancer	0.0091	0.014	CcSEcCtD
Rescinnamine—Stinging—Imiquimod—skin cancer	0.00903	0.0139	CcSEcCtD
Rescinnamine—SLC18A2—female reproductive system—skin cancer	0.00893	0.0254	CbGeAlD
Rescinnamine—Skin hyperpigmentation—Bleomycin—skin cancer	0.00873	0.0135	CcSEcCtD
Rescinnamine—ACE—connective tissue—skin cancer	0.00865	0.0246	CbGeAlD
Rescinnamine—ACE—epithelium—skin cancer	0.00821	0.0233	CbGeAlD
Rescinnamine—SLC18A2—head—skin cancer	0.00746	0.0212	CbGeAlD
Rescinnamine—Bullous eruption—Docetaxel—skin cancer	0.00737	0.0114	CcSEcCtD
Rescinnamine—Vaginal inflammation—Imiquimod—skin cancer	0.00731	0.0113	CcSEcCtD
Rescinnamine—ACE—mammalian vulva—skin cancer	0.00712	0.0202	CbGeAlD
Rescinnamine—Vaginal infection—Imiquimod—skin cancer	0.0069	0.0107	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Fluorouracil—skin cancer	0.00679	0.0105	CcSEcCtD
Rescinnamine—Tooth disorder—Temozolomide—skin cancer	0.00676	0.0104	CcSEcCtD
Rescinnamine—ACE—lymphoid tissue—skin cancer	0.00632	0.018	CbGeAlD
Rescinnamine—ACE—female reproductive system—skin cancer	0.0061	0.0173	CbGeAlD
Rescinnamine—Dysgeusia—Vismodegib—skin cancer	0.00594	0.00917	CcSEcCtD
Rescinnamine—Back pain—Vismodegib—skin cancer	0.00587	0.00906	CcSEcCtD
Rescinnamine—Herpes zoster—Temozolomide—skin cancer	0.00582	0.00898	CcSEcCtD
Rescinnamine—Injury—Imiquimod—skin cancer	0.00577	0.00891	CcSEcCtD
Rescinnamine—Endocrine disorder—Temozolomide—skin cancer	0.00529	0.00816	CcSEcCtD
Rescinnamine—SLC18A2—lymph node—skin cancer	0.00522	0.0148	CbGeAlD
Rescinnamine—Myalgia—Vismodegib—skin cancer	0.00517	0.00797	CcSEcCtD
Rescinnamine—ACE—head—skin cancer	0.00509	0.0145	CbGeAlD
Rescinnamine—Tingling sensation—Fluorouracil—skin cancer	0.00502	0.00775	CcSEcCtD
Rescinnamine—Stinging—Fluorouracil—skin cancer	0.00498	0.00769	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Vemurafenib—skin cancer	0.00491	0.00758	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Docetaxel—skin cancer	0.0049	0.00756	CcSEcCtD
Rescinnamine—Eye irritation—Fluorouracil—skin cancer	0.00473	0.0073	CcSEcCtD
Rescinnamine—Influenza—Imiquimod—skin cancer	0.00459	0.00708	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00451	0.00696	CcSEcCtD
Rescinnamine—Bronchitis—Imiquimod—skin cancer	0.00441	0.00681	CcSEcCtD
Rescinnamine—Vaginal inflammation—Temozolomide—skin cancer	0.00438	0.00676	CcSEcCtD
Rescinnamine—Lacrimation increased—Fluorouracil—skin cancer	0.00438	0.00676	CcSEcCtD
Rescinnamine—Redness—Docetaxel—skin cancer	0.00432	0.00666	CcSEcCtD
Rescinnamine—Constipation—Vismodegib—skin cancer	0.00423	0.00653	CcSEcCtD
Rescinnamine—Pain—Vismodegib—skin cancer	0.00423	0.00653	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Imiquimod—skin cancer	0.00419	0.00646	CcSEcCtD
Rescinnamine—Vaginal infection—Temozolomide—skin cancer	0.00414	0.00638	CcSEcCtD
Rescinnamine—Injury—Bleomycin—skin cancer	0.0041	0.00633	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Vismodegib—skin cancer	0.00405	0.00625	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Imiquimod—skin cancer	0.00403	0.00622	CcSEcCtD
Rescinnamine—Myocardial infarction—Imiquimod—skin cancer	0.00401	0.00619	CcSEcCtD
Rescinnamine—Dermatitis contact—Fluorouracil—skin cancer	0.00399	0.00616	CcSEcCtD
Rescinnamine—Conjunctivitis—Imiquimod—skin cancer	0.00398	0.00614	CcSEcCtD
Rescinnamine—Urinary tract infection—Imiquimod—skin cancer	0.00398	0.00614	CcSEcCtD
Rescinnamine—Abdominal pain—Vismodegib—skin cancer	0.00391	0.00604	CcSEcCtD
Rescinnamine—Sinusitis—Imiquimod—skin cancer	0.00384	0.00592	CcSEcCtD
Rescinnamine—Erythema—Vemurafenib—skin cancer	0.00375	0.00578	CcSEcCtD
Rescinnamine—Rhinitis—Imiquimod—skin cancer	0.00368	0.00568	CcSEcCtD
Rescinnamine—Dysgeusia—Vemurafenib—skin cancer	0.00367	0.00566	CcSEcCtD
Rescinnamine—Pharyngitis—Imiquimod—skin cancer	0.00364	0.00562	CcSEcCtD
Rescinnamine—Back pain—Vemurafenib—skin cancer	0.00363	0.0056	CcSEcCtD
Rescinnamine—ACE—lymph node—skin cancer	0.00357	0.0101	CbGeAlD
Rescinnamine—Pruritus—Vismodegib—skin cancer	0.0035	0.00541	CcSEcCtD
Rescinnamine—Eye irritation—Docetaxel—skin cancer	0.00341	0.00527	CcSEcCtD
Rescinnamine—Cough—Vemurafenib—skin cancer	0.00327	0.00505	CcSEcCtD
Rescinnamine—Erythema—Imiquimod—skin cancer	0.0032	0.00493	CcSEcCtD
Rescinnamine—Myalgia—Vemurafenib—skin cancer	0.00319	0.00492	CcSEcCtD
Rescinnamine—Lacrimation increased—Docetaxel—skin cancer	0.00316	0.00488	CcSEcCtD
Rescinnamine—Rash—Vismodegib—skin cancer	0.00312	0.00482	CcSEcCtD
Rescinnamine—Dermatitis—Vismodegib—skin cancer	0.00312	0.00481	CcSEcCtD
Rescinnamine—Back pain—Imiquimod—skin cancer	0.00309	0.00477	CcSEcCtD
Rescinnamine—Dermatitis bullous—Fluorouracil—skin cancer	0.00307	0.00473	CcSEcCtD
Rescinnamine—Infection—Vemurafenib—skin cancer	0.00304	0.00469	CcSEcCtD
Rescinnamine—Nausea—Vismodegib—skin cancer	0.00294	0.00454	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Bleomycin—skin cancer	0.00286	0.00442	CcSEcCtD
Rescinnamine—Myocardial infarction—Bleomycin—skin cancer	0.00285	0.0044	CcSEcCtD
Rescinnamine—Cough—Imiquimod—skin cancer	0.00279	0.0043	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00279	0.0043	CcSEcCtD
Rescinnamine—Hypertension—Imiquimod—skin cancer	0.00276	0.00426	CcSEcCtD
Rescinnamine—Myalgia—Imiquimod—skin cancer	0.00272	0.0042	CcSEcCtD
Rescinnamine—Discomfort—Imiquimod—skin cancer	0.00269	0.00415	CcSEcCtD
Rescinnamine—Bronchitis—Temozolomide—skin cancer	0.00264	0.00408	CcSEcCtD
Rescinnamine—Constipation—Vemurafenib—skin cancer	0.00262	0.00404	CcSEcCtD
Rescinnamine—Oedema—Imiquimod—skin cancer	0.00261	0.00403	CcSEcCtD
Rescinnamine—Hypoaesthesia—Bleomycin—skin cancer	0.0026	0.00401	CcSEcCtD
Rescinnamine—Infection—Imiquimod—skin cancer	0.00259	0.004	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Temozolomide—skin cancer	0.00251	0.00387	CcSEcCtD
Rescinnamine—Angina pectoris—Fluorouracil—skin cancer	0.00247	0.00381	CcSEcCtD
Rescinnamine—Pharyngitis—Dactinomycin—skin cancer	0.00241	0.00373	CcSEcCtD
Rescinnamine—Urinary tract infection—Temozolomide—skin cancer	0.00238	0.00368	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00238	0.00367	CcSEcCtD
Rescinnamine—Insomnia—Imiquimod—skin cancer	0.00236	0.00364	CcSEcCtD
Rescinnamine—Paraesthesia—Imiquimod—skin cancer	0.00234	0.00362	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Fluorouracil—skin cancer	0.00231	0.00357	CcSEcCtD
Rescinnamine—Sinusitis—Temozolomide—skin cancer	0.0023	0.00355	CcSEcCtD
Rescinnamine—Erythema—Bleomycin—skin cancer	0.00227	0.0035	CcSEcCtD
Rescinnamine—Hypersensitivity—Vemurafenib—skin cancer	0.00225	0.00348	CcSEcCtD
Rescinnamine—Pain—Imiquimod—skin cancer	0.00223	0.00344	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Fluorouracil—skin cancer	0.00223	0.00344	CcSEcCtD
Rescinnamine—Myocardial infarction—Fluorouracil—skin cancer	0.00221	0.00342	CcSEcCtD
Rescinnamine—Dermatitis bullous—Docetaxel—skin cancer	0.00221	0.00342	CcSEcCtD
Rescinnamine—Urinary tract infection—Fluorouracil—skin cancer	0.0022	0.00339	CcSEcCtD
Rescinnamine—Conjunctivitis—Fluorouracil—skin cancer	0.0022	0.00339	CcSEcCtD
Rescinnamine—Hypoaesthesia—Temozolomide—skin cancer	0.00219	0.00338	CcSEcCtD
Rescinnamine—Pharyngitis—Temozolomide—skin cancer	0.00218	0.00337	CcSEcCtD
Rescinnamine—Pruritus—Vemurafenib—skin cancer	0.00216	0.00334	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Imiquimod—skin cancer	0.00213	0.00329	CcSEcCtD
Rescinnamine—Sinusitis—Fluorouracil—skin cancer	0.00212	0.00327	CcSEcCtD
Rescinnamine—Erythema—Dactinomycin—skin cancer	0.00212	0.00327	CcSEcCtD
Rescinnamine—Urticaria—Imiquimod—skin cancer	0.00207	0.0032	CcSEcCtD
Rescinnamine—Abdominal pain—Imiquimod—skin cancer	0.00206	0.00318	CcSEcCtD
Rescinnamine—Rhinitis—Fluorouracil—skin cancer	0.00203	0.00314	CcSEcCtD
Rescinnamine—Dizziness—Vemurafenib—skin cancer	0.00202	0.00312	CcSEcCtD
Rescinnamine—Hypoaesthesia—Fluorouracil—skin cancer	0.00202	0.00311	CcSEcCtD
Rescinnamine—Pharyngitis—Fluorouracil—skin cancer	0.00201	0.00311	CcSEcCtD
Rescinnamine—Cough—Bleomycin—skin cancer	0.00198	0.00306	CcSEcCtD
Rescinnamine—Myalgia—Bleomycin—skin cancer	0.00193	0.00298	CcSEcCtD
Rescinnamine—Rash—Vemurafenib—skin cancer	0.00193	0.00298	CcSEcCtD
Rescinnamine—Dermatitis—Vemurafenib—skin cancer	0.00193	0.00297	CcSEcCtD
Rescinnamine—Hypersensitivity—Imiquimod—skin cancer	0.00192	0.00297	CcSEcCtD
Rescinnamine—Headache—Vemurafenib—skin cancer	0.00192	0.00296	CcSEcCtD
Rescinnamine—Erythema—Temozolomide—skin cancer	0.00192	0.00296	CcSEcCtD
Rescinnamine—Discomfort—Bleomycin—skin cancer	0.00191	0.00295	CcSEcCtD
Rescinnamine—Dysgeusia—Temozolomide—skin cancer	0.00188	0.0029	CcSEcCtD
Rescinnamine—Oedema—Bleomycin—skin cancer	0.00185	0.00286	CcSEcCtD
Rescinnamine—Back pain—Temozolomide—skin cancer	0.00185	0.00286	CcSEcCtD
Rescinnamine—Pruritus—Imiquimod—skin cancer	0.00185	0.00285	CcSEcCtD
Rescinnamine—Infection—Bleomycin—skin cancer	0.00184	0.00284	CcSEcCtD
Rescinnamine—Nausea—Vemurafenib—skin cancer	0.00182	0.0028	CcSEcCtD
Rescinnamine—Myalgia—Dactinomycin—skin cancer	0.0018	0.00278	CcSEcCtD
Rescinnamine—Discomfort—Dactinomycin—skin cancer	0.00178	0.00275	CcSEcCtD
Rescinnamine—Angina pectoris—Docetaxel—skin cancer	0.00178	0.00275	CcSEcCtD
Rescinnamine—Erythema—Fluorouracil—skin cancer	0.00177	0.00272	CcSEcCtD
Rescinnamine—Oedema—Dactinomycin—skin cancer	0.00173	0.00267	CcSEcCtD
Rescinnamine—Dizziness—Imiquimod—skin cancer	0.00173	0.00266	CcSEcCtD
Rescinnamine—Infection—Dactinomycin—skin cancer	0.00172	0.00265	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00169	0.00261	CcSEcCtD
Rescinnamine—Cough—Temozolomide—skin cancer	0.00167	0.00258	CcSEcCtD
Rescinnamine—Paraesthesia—Bleomycin—skin cancer	0.00166	0.00257	CcSEcCtD
Rescinnamine—Hypertension—Temozolomide—skin cancer	0.00165	0.00255	CcSEcCtD
Rescinnamine—Rash—Imiquimod—skin cancer	0.00164	0.00254	CcSEcCtD
Rescinnamine—Dermatitis—Imiquimod—skin cancer	0.00164	0.00254	CcSEcCtD
Rescinnamine—Headache—Imiquimod—skin cancer	0.00163	0.00252	CcSEcCtD
Rescinnamine—Myalgia—Temozolomide—skin cancer	0.00163	0.00252	CcSEcCtD
Rescinnamine—Discomfort—Temozolomide—skin cancer	0.00161	0.00249	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Docetaxel—skin cancer	0.00161	0.00248	CcSEcCtD
Rescinnamine—Myocardial infarction—Docetaxel—skin cancer	0.0016	0.00247	CcSEcCtD
Rescinnamine—Pain—Bleomycin—skin cancer	0.00158	0.00245	CcSEcCtD
Rescinnamine—Conjunctivitis—Docetaxel—skin cancer	0.00158	0.00245	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00157	0.00243	CcSEcCtD
Rescinnamine—Oedema—Temozolomide—skin cancer	0.00156	0.00241	CcSEcCtD
Rescinnamine—Infection—Temozolomide—skin cancer	0.00155	0.0024	CcSEcCtD
Rescinnamine—Nausea—Imiquimod—skin cancer	0.00155	0.00239	CcSEcCtD
Rescinnamine—Myalgia—Fluorouracil—skin cancer	0.0015	0.00232	CcSEcCtD
Rescinnamine—Discomfort—Fluorouracil—skin cancer	0.00148	0.00229	CcSEcCtD
Rescinnamine—Pain—Dactinomycin—skin cancer	0.00148	0.00228	CcSEcCtD
Rescinnamine—Urticaria—Bleomycin—skin cancer	0.00147	0.00227	CcSEcCtD
Rescinnamine—Rhinitis—Docetaxel—skin cancer	0.00147	0.00226	CcSEcCtD
Rescinnamine—Hypoaesthesia—Docetaxel—skin cancer	0.00146	0.00225	CcSEcCtD
Rescinnamine—Pharyngitis—Docetaxel—skin cancer	0.00145	0.00224	CcSEcCtD
Rescinnamine—Oedema—Fluorouracil—skin cancer	0.00144	0.00222	CcSEcCtD
Rescinnamine—Infection—Fluorouracil—skin cancer	0.00143	0.00221	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00142	0.0022	CcSEcCtD
Rescinnamine—Insomnia—Temozolomide—skin cancer	0.00141	0.00218	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Dactinomycin—skin cancer	0.00141	0.00218	CcSEcCtD
Rescinnamine—Paraesthesia—Temozolomide—skin cancer	0.0014	0.00217	CcSEcCtD
Rescinnamine—Abdominal pain—Dactinomycin—skin cancer	0.00137	0.00211	CcSEcCtD
Rescinnamine—Hypersensitivity—Bleomycin—skin cancer	0.00137	0.00211	CcSEcCtD
Rescinnamine—Constipation—Temozolomide—skin cancer	0.00134	0.00206	CcSEcCtD
Rescinnamine—Pain—Temozolomide—skin cancer	0.00134	0.00206	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00131	0.00203	CcSEcCtD
Rescinnamine—Pruritus—Bleomycin—skin cancer	0.00131	0.00202	CcSEcCtD
Rescinnamine—Insomnia—Fluorouracil—skin cancer	0.0013	0.00201	CcSEcCtD
Rescinnamine—Paraesthesia—Fluorouracil—skin cancer	0.00129	0.002	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Temozolomide—skin cancer	0.00128	0.00197	CcSEcCtD
Rescinnamine—Erythema—Docetaxel—skin cancer	0.00127	0.00197	CcSEcCtD
Rescinnamine—Hypersensitivity—Dactinomycin—skin cancer	0.00127	0.00197	CcSEcCtD
Rescinnamine—Dysgeusia—Docetaxel—skin cancer	0.00125	0.00193	CcSEcCtD
Rescinnamine—Urticaria—Temozolomide—skin cancer	0.00124	0.00192	CcSEcCtD
Rescinnamine—Abdominal pain—Temozolomide—skin cancer	0.00124	0.00191	CcSEcCtD
Rescinnamine—Back pain—Docetaxel—skin cancer	0.00123	0.0019	CcSEcCtD
Rescinnamine—Pain—Fluorouracil—skin cancer	0.00123	0.0019	CcSEcCtD
Rescinnamine—Rash—Bleomycin—skin cancer	0.00117	0.0018	CcSEcCtD
Rescinnamine—Dermatitis—Bleomycin—skin cancer	0.00117	0.0018	CcSEcCtD
Rescinnamine—Hypersensitivity—Temozolomide—skin cancer	0.00115	0.00178	CcSEcCtD
Rescinnamine—Urticaria—Fluorouracil—skin cancer	0.00114	0.00177	CcSEcCtD
Rescinnamine—Cough—Docetaxel—skin cancer	0.00111	0.00172	CcSEcCtD
Rescinnamine—Pruritus—Temozolomide—skin cancer	0.00111	0.00171	CcSEcCtD
Rescinnamine—Nausea—Bleomycin—skin cancer	0.0011	0.0017	CcSEcCtD
Rescinnamine—Hypertension—Docetaxel—skin cancer	0.0011	0.0017	CcSEcCtD
Rescinnamine—Rash—Dactinomycin—skin cancer	0.00109	0.00168	CcSEcCtD
Rescinnamine—Myalgia—Docetaxel—skin cancer	0.00108	0.00167	CcSEcCtD
Rescinnamine—Hypersensitivity—Fluorouracil—skin cancer	0.00106	0.00164	CcSEcCtD
Rescinnamine—Oedema—Docetaxel—skin cancer	0.00104	0.0016	CcSEcCtD
Rescinnamine—Dizziness—Temozolomide—skin cancer	0.00103	0.0016	CcSEcCtD
Rescinnamine—Infection—Docetaxel—skin cancer	0.00103	0.00159	CcSEcCtD
Rescinnamine—Nausea—Dactinomycin—skin cancer	0.00103	0.00158	CcSEcCtD
Rescinnamine—Pruritus—Fluorouracil—skin cancer	0.00102	0.00157	CcSEcCtD
Rescinnamine—Rash—Temozolomide—skin cancer	0.000986	0.00152	CcSEcCtD
Rescinnamine—Dermatitis—Temozolomide—skin cancer	0.000985	0.00152	CcSEcCtD
Rescinnamine—Headache—Temozolomide—skin cancer	0.000979	0.00151	CcSEcCtD
Rescinnamine—Dizziness—Fluorouracil—skin cancer	0.000953	0.00147	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000947	0.00146	CcSEcCtD
Rescinnamine—Insomnia—Docetaxel—skin cancer	0.00094	0.00145	CcSEcCtD
Rescinnamine—Paraesthesia—Docetaxel—skin cancer	0.000934	0.00144	CcSEcCtD
Rescinnamine—Nausea—Temozolomide—skin cancer	0.000929	0.00143	CcSEcCtD
Rescinnamine—Rash—Fluorouracil—skin cancer	0.000908	0.0014	CcSEcCtD
Rescinnamine—Dermatitis—Fluorouracil—skin cancer	0.000907	0.0014	CcSEcCtD
Rescinnamine—Headache—Fluorouracil—skin cancer	0.000902	0.00139	CcSEcCtD
Rescinnamine—Constipation—Docetaxel—skin cancer	0.000889	0.00137	CcSEcCtD
Rescinnamine—Pain—Docetaxel—skin cancer	0.000889	0.00137	CcSEcCtD
Rescinnamine—Nausea—Fluorouracil—skin cancer	0.000856	0.00132	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Docetaxel—skin cancer	0.00085	0.00131	CcSEcCtD
Rescinnamine—Abdominal pain—Docetaxel—skin cancer	0.000822	0.00127	CcSEcCtD
Rescinnamine—Hypersensitivity—Docetaxel—skin cancer	0.000766	0.00118	CcSEcCtD
Rescinnamine—Pruritus—Docetaxel—skin cancer	0.000736	0.00114	CcSEcCtD
Rescinnamine—Dizziness—Docetaxel—skin cancer	0.000688	0.00106	CcSEcCtD
Rescinnamine—Rash—Docetaxel—skin cancer	0.000656	0.00101	CcSEcCtD
Rescinnamine—Dermatitis—Docetaxel—skin cancer	0.000655	0.00101	CcSEcCtD
Rescinnamine—Headache—Docetaxel—skin cancer	0.000651	0.00101	CcSEcCtD
Rescinnamine—Nausea—Docetaxel—skin cancer	0.000618	0.000953	CcSEcCtD
